460 related articles for article (PubMed ID: 38475833)
1. Efficacy and safety of gut microbiota-based therapies in autoimmune and rheumatic diseases: a systematic review and meta-analysis of 80 randomized controlled trials.
Zeng L; Yang K; He Q; Zhu X; Long Z; Wu Y; Chen J; Li Y; Zeng J; Cui G; Xiang W; Hao W; Sun L
BMC Med; 2024 Mar; 22(1):110. PubMed ID: 38475833
[TBL] [Abstract][Full Text] [Related]
2. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.
Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H
Front Immunol; 2022; 13():896476. PubMed ID: 35979355
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of probiotic supplementation in 8 types of inflammatory arthritis: A systematic review and meta-analysis of 34 randomized controlled trials.
Zeng L; Deng Y; He Q; Yang K; Li J; Xiang W; Liu H; Zhu X; Chen H
Front Immunol; 2022; 13():961325. PubMed ID: 36217542
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: A systematic review and meta-analysis.
Zeng L; Deng Y; Yang K; Chen J; He Q; Chen H
Front Immunol; 2022; 13():944387. PubMed ID: 36248877
[TBL] [Abstract][Full Text] [Related]
5. Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity.
Sardu C; Cocco E; Mereu A; Massa R; Cuccu A; Marrosu MG; Contu P
PLoS One; 2012; 7(3):e32487. PubMed ID: 22396771
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases.
Li CY; Yang TM; Ou RW; Wei QQ; Shang HF
BMC Med; 2021 Feb; 19(1):27. PubMed ID: 33541344
[TBL] [Abstract][Full Text] [Related]
7. Celiac disease arthropathy and autoimmunity study.
Iqbal T; Zaidi MA; Wells GA; Karsh J
J Gastroenterol Hepatol; 2013 Jan; 28(1):99-105. PubMed ID: 22988822
[TBL] [Abstract][Full Text] [Related]
8. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
Dang X; Xu M; Liu D; Zhou D; Yang W
PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of gut microbiota in autoimmune diseases.
Wang X; Yuan W; Yang C; Wang Z; Zhang J; Xu D; Sun X; Sun W
Front Immunol; 2024; 15():1365554. PubMed ID: 38765017
[TBL] [Abstract][Full Text] [Related]
10. The Association of Inflammatory Bowel Diseases with Autoimmune Disorders: A Report from the epi-IIRN.
Bar Yehuda S; Axlerod R; Toker O; Zigman N; Goren I; Mourad V; Lederman N; Cohen N; Matz E; Dushnitzky D; Gavish M; Borovsky N; Schwarts D; Dotan I; Turner D
J Crohns Colitis; 2019 Mar; 13(3):324-329. PubMed ID: 30304371
[TBL] [Abstract][Full Text] [Related]
11. [Cardiovascular and pupillary autonomic and somatosensory neuropathy in chronic diseases with autoimmune phenomena. A comparative study of patients with Crohn disease, ulcerative colitis, systemic lupus erythematosus, progressive systemic sclerosis and type I diabetes mellitus].
Straub RH; Andus T; Lock G; Zeuner M; Palitzsch KD; Gross V; Lang B; Schölmerich J
Med Klin (Munich); 1997 Nov; 92(11):647-53. PubMed ID: 9480395
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.
Miao XP; Li JS; Ouyang Q; Hu RW; Zhang Y; Li HY
Cochrane Database Syst Rev; 2014 Oct; (10):CD007744. PubMed ID: 25340915
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diseases and adverse pregnancy outcomes: an umbrella review.
Singh M; Wambua S; Lee SI; Okoth K; Wang Z; Fayaz FFA; Eastwood KA; Nelson-Piercy C; Reynolds JA; Nirantharakumar K; Crowe F;
BMC Med; 2024 Mar; 22(1):94. PubMed ID: 38438886
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease.
Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L
Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226
[TBL] [Abstract][Full Text] [Related]
15. Fecal transplantation for treatment of inflammatory bowel disease.
Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of iguratimod in the treatment of rheumatic and autoimmune diseases: a meta-analysis and systematic review of 84 randomized controlled trials.
Zeng L; He Q; Deng Y; Li Y; Chen J; Yang K; Luo Y; Ge A; Zhu X; Long Z; Sun L
Front Pharmacol; 2023; 14():1189142. PubMed ID: 38143490
[No Abstract] [Full Text] [Related]
17. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
Naseer M; Poola S; Ali S; Samiullah S; Tahan V
Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
[TBL] [Abstract][Full Text] [Related]
18. Probiotics for induction of remission in ulcerative colitis.
Kaur L; Gordon M; Baines PA; Iheozor-Ejiofor Z; Sinopoulou V; Akobeng AK
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD005573. PubMed ID: 32128795
[TBL] [Abstract][Full Text] [Related]
19. Gut dysbiosis in rheumatic diseases: A systematic review and meta-analysis of 92 observational studies.
Wang Y; Wei J; Zhang W; Doherty M; Zhang Y; Xie H; Li W; Wang N; Lei G; Zeng C
EBioMedicine; 2022 Jun; 80():104055. PubMed ID: 35594658
[TBL] [Abstract][Full Text] [Related]
20. Probiotics for induction of remission in Crohn's disease.
Limketkai BN; Akobeng AK; Gordon M; Adepoju AA
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD006634. PubMed ID: 32678465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
